Dr. Bradley S. Rosen, M.D.

Dr. Bradley S. Rosen, M.D. graduated with High Honors from the University of Florida with a degree in Mathematics and Statistics in 1987. After taking time to study Spanish (Spain) and Molecular Biology (Middle East), Dr. Bradley S. Rosen, M.D. returned to the University of Florida where he graduated with Highest Honors in 1992.

From there he undertook Residency training at the world-renowned Jules Stein Eye Institute at the UCLA Medical Center, followed by 2 separate Retina Fellowships at the Lions Eye Institute- the largest Eye Research Center in the Southern Hemisphere, and the equally prestigious Royal Victorian Eye and Ear Hospital in Melbourne Australia.

Dr. Bradley S. Rosen, M.D. spent a year in Bali Indonesia as a volunteer surgeon before returning to Los Angeles and founding the Retina Service at the Kaiser West Los Angeles Medical Center in 2000.

Around 2013 Dr. Bradley S. Rosen, M.D. joined a growing number of scientists and clinicians who are becoming increasingly interested in the fact that the process of aging itself is the biggest risk factor for virtually all the diseases of adulthood, especially those that tend to afflict people from the age of 40 on….and that the hallmarks of aging themselves can and should be targeted for therapy.

Since that time his interests have been in identifying and reducing the known standard risk factors that shorten our healthspan, and following the science and clinical work around gero-science and life extension. In a space with many unknowns, Dr. Bradley S. Rosen, M.D. strives to follow evidence and help patients optimize their understanding of risks and potential rewards so they can make decisions that help them optimize their chances for a longer period of resilient health.

While there is no currently available technology to stop aging, Dr. Bradley S. Rosen, M.D. believes that the paradigm of life and healthspan extension is a powerful way to view one’s healthcare, and early indications are promising that use of mTOR inhibition, and modification of certain metabolic pathways may indeed begin to slow the rate at which we age and result in a meaningful extension of the time we spend unburdened by age-related disease. He opened this practice to give individuals who share that vision an opportunity to access certain of the medications associated with mTOR inhibition and other important pathways, and to re-assess their own medical goals through the lens of healthspan extension.

Let’s Get Social & Learn More About Dr. Bradley S. Rosen, M.D.